Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-557-4 | CAS number: 84-74-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- publication
- Title:
- Dibutyl phthalate
- Author:
- Australian Government, Department of Health, NATIONAL INDUSTRIAL CHEMICALS NOTIFICATION AND ASSESSMENT SCHEME GPO Box 58, Sydney NSW 2001 AUSTRALIA www.nicnas.gov.au
- Year:
- 2 013
- Bibliographic source:
- Priority Existing Chemical Assessment Report No. 36, ISBN 978-0-9874434-4-1
Materials and methods
Results and discussion
Applicant's summary and conclusion
- Conclusions:
- DBP absorption via the dermal route in humans is low .
Dermal absorption in rat is 40 times higher in comparison to humans, therefore studies in rats about dermal DBP absorption are not representative for human skin. - Executive summary:
Absorption via the dermal route and subsequent elimination was assessed after application of 43.7 mg/kg 14C-DBP in ethanol (with occlusion) to the clipped skin of male F344 rats, followed by measurements of the excreted 14C radiolabel. Over seven days, DBP was excreted in urine and faeces at a nearly constant rate of approximately 10–12 % of the applied dose each day. Around one third of the applied dose remained at the site of application (Elsisi et al. 1989). In a comparative in vitro study, Scott et al. (1987) demonstrated that the rate of dermal absorption for DBP is about 40 times greater in rat than in human epidermal skin preparations (93.35 μg/cm2/h and 2.40 μg/cm2/h, respectively). More recently, Janjua et al. (2007 ND, 2008 ND) examined systemic uptake and elimination of DBP after dermal application in human volunteers. About 40 g of a standard cosmetic lotion formulation without (during control week) or with 2 % DBP (during treatment week) was applied to the whole body of 26 adult males for five consecutive days. The volunteers did not use any phthalate containing cosmetics for three weeks before the treatment week. Serum and urine concentrations of the primary metabolite, monobutyl phthalate (MBP), were measured. Urine was collected as individual samples at different time points during the first day of the treatment week and as 24-hour pools on all consecutive days. Results demonstrated increases in MBP in serum and urine within a few hours of application. An average of 1.82 % (range 0.11–5.94 %) of the applied DBP dose was recovered in urine as MBP during the treatment week. Taking into consideration the studies in rodents that demonstrate absence of significant bioaccumulation of DBP in any organs or tissues, the studies by Janjua et al. suggest that DBP absorption via the dermal route in humans under conditions of usual cosmetic application is low. A study with hairless guinea pigs (Doan et al. 2010 ND) that compared in vivo and in vitro skin absorption of DBP from an oil-in-water emulsion, found that in vivo, 62.0 % ±2.0 % (mean of three animals ±SEM) of the applied dose (AD) was systematically absorbed. Most of this (60.4 ±1.8 %AD) was excreted in the urine and less than 2 % was found in other tissues (ovaries, kidneys, liver). The amount of applied dose retained in the skin after 24 hours was 2.2 ±0.3 % AD; 7.4 ±2.3 % AD was trapped as volatile material in the first hour after dosing. The amount of DBP absorbed in vivo after 24 hours closely agreed with the amount of DBP found in the receptor fluid in vitro after 72 hours, suggesting that in vitro DBP is a lipophilic chemical that can initially form a reservoir in skin, and can slowly diffuse out of the skin into the receptor fluid. The relative permeability of human and guinea pig skin for DBP from this particular oil-in-water emulsion has not been compared.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.